or Try an Advanced Search...

    Technical Analysis for CARM - Carisma Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.84 -2.60% -0.02
    CARM closed down 0.54 percent on Wednesday, November 20, 2024, on 59 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CARM trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -2.60%
    Outside Day Range Expansion -2.60%
    Down 3 Days in a Row Weakness -2.60%
    Down 4 Days in a Row Weakness -2.60%
    Down 5 Days in a Row Weakness -2.60%
    Oversold Stochastic Weakness -2.60%
    Lower Bollinger Band Walk Weakness -3.13%
    Gapped Up Strength -3.13%
    Below Lower BB Weakness -3.13%
    Down 3 Days in a Row Weakness -3.13%
    Older End-of-Day Signals for CARM ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 1 hour ago
    Down 3% about 1 hour ago
    Fell Below Lower Bollinger Band about 1 hour ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 2 % about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CARM Chart by TradingView
    Basic chart:

    Profile

    Carisma Therapeutics Inc. is a biopharmaceutical company dedicated to developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania*, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Solid Tumors Immune System Cell Therapy Chimeric Antigen Receptor T Cell Natural Killer Cell Antigen Induced Stem Cells

    Is CARM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting® 2024
    Nov 8 Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
    Nov 7 Carisma Therapeutics reports Q3 results
    Nov 7 Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
    Nov 5 Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
    Oct 30 Carisma Therapeutics Announces Changes to its Board of Directors
    Oct 4 Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
    Sep 10 Carisma Therapeutics, Moderna Expand Collaboration Into Autoimmune Diseases
    Sep 10 Moderna, Carisma deal expands with autoimmune targets
    Sep 10 Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
    See more CARM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.16
    52 Week Low 0.8
    Average Volume 138,251
    200-Day Moving Average 1.43
    50-Day Moving Average 0.98
    20-Day Moving Average 0.98
    10-Day Moving Average 0.94
    Average True Range 0.06
    RSI (14) 32.43
    ADX 17.2
    +DI 16.10
    -DI 27.30
    Chandelier Exit (Long, 3 ATRs) 0.96
    Chandelier Exit (Short, 3 ATRs) 1.02
    Upper Bollinger Bands 1.12
    Lower Bollinger Band 0.85
    Percent B (%b) 0.05
    BandWidth 27.47
    MACD Line -0.03
    MACD Signal Line -0.01
    MACD Histogram -0.0197
    Fundamentals Value
    Market Cap 34.8 Million
    Num Shares 40.4 Million
    EPS -1.21
    Price-to-Earnings (P/E) Ratio -0.71
    Price-to-Sales 6.51
    Price-to-Book 1.83
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.94
    Resistance 3 (R3) 0.94 0.92 0.93
    Resistance 2 (R2) 0.92 0.90 0.92 0.92
    Resistance 1 (R1) 0.89 0.89 0.88 0.89 0.92
    Pivot Point 0.87 0.87 0.87 0.87 0.87
    Support 1 (S1) 0.84 0.85 0.83 0.84 0.81
    Support 2 (S2) 0.82 0.84 0.82 0.80
    Support 3 (S3) 0.79 0.82 0.80
    Support 4 (S4) 0.78